arrow_back Back to App

Faster Approval for Emergency Drugs and Medical Devices

This act allows data collected during emergencies (e.g., pandemics) to be used for faster approval of drugs, biological products, and medical devices. This means products proven effective in a crisis can reach the market for general use more quickly, potentially improving access to vital therapies and diagnostic tools.
Key points
Emergency use data (e.g., vaccines, tests) can now support permanent product approval.
Speeds up market entry for drugs and devices proven effective in crisis situations.
Ensures safety and efficacy standards remain, but the evaluation process is more flexible.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_HR_4511
Sponsor: Rep. Burgess, Michael C. [R-TX-26]
Process start date: 2021-07-19